|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paediatric Heart Institute, Hospital Universitario "12 de Octubre", Carretera de Andalucía, km 5, 400, Edificio Materno-Infantil, 28041 Madrid, Spain
(Email: jvc@mi.madritel.es).
| The first 20% of the full text of this article appears below. |
The management of truncus arteriosus has evolved, and results are now more consistent [1]. As has been well described, however, the primary approach to truncus arteriosus and to significant associated lesions, such as interrupted aortic arch and truncal valve insufficiency, remain the major risk factors for reoperation and mid to late survival rates. The initial management of truncal valve is a good example of the problems that arise when pediatric cardiac surgeons try to standardize therapy.
The lack of consensus
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |